Filters
Hikma launches Labetalol Hydrochloride Injection in ready-to-use bags
Press Release, Product
Meet the Management Series – Branded
Press Release, Corporate
Hikma launches Hydralazine Hydrochloride Injection, USP
Press Release, Product
Hikma launches Docetaxel Injection, USP
Press Release, Product
Hikma launches Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection
Press Release, Product
Hikma announces good start to 2021 and reiterates full year guidance
Press Release, Corporate
Hikma announces US FDA approval of KLOXXADO TM (naloxone hydrochloride) nasal spray 8mg
Press Release, Corporate
Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and ...
Press Release, Corporate
Hikma announces exclusive agreement with AFT Pharmaceuticals for injectable non-opioid pain medication Combogesic® IV in...
Press Release, Corporate
Hikma resumes launch of generic Advair Diskus®
Press Release, Product
Hikma pledges additional $40,000 to local US food banks and pantries in fight against hunger
Press Release, Responsibility
REMINDER Injectables Meet the Management 24 March 2021, 2:00pm to 3:30pm
Press Release, Corporate
Hikma and GSK agree to cease potential acquisition discussions in Egypt and Tunisia
Press Release, Corporate
Hikma launches generic version of Northera®
Press Release, Product